Robert Bruce's ABBV Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 122,500 shares of AbbVie Inc. (ABBV) worth $27.99 M, representing 8.68% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Robert Bruce has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 64,749 shares. Largest reduction occurred in Q3 2021, reducing 64,626 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Robert Bruce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -5,000 | Reduce 3.92% | 122,500 | $228.49 |
| Q1 2025 | -10,000 | Reduce 7.27% | 127,500 | $209.52 |
| Q4 2024 | -9,000 | Reduce 6.14% | 137,500 | $177.70 |
| Q3 2024 | -15,000 | Reduce 9.29% | 146,500 | $197.48 |
| Q2 2024 | +23,500 | Add 17.03% | 161,500 | $171.52 |
| Q4 2023 | -25,000 | Reduce 15.34% | 138,000 | $154.97 |
| Q3 2023 | -28,743 | Reduce 14.99% | 163,000 | $149.06 |
| Q1 2023 | -10,757 | Reduce 5.31% | 191,743 | $159.37 |
| Q4 2022 | -21,000 | Reduce 9.40% | 202,500 | $161.61 |
| Q2 2022 | -20,000 | Reduce 8.21% | 223,500 | $153.16 |
| Q1 2022 | -60,000 | Reduce 19.77% | 243,500 | $162.11 |
| Q3 2021 | -64,626 | Reduce 17.56% | 303,500 | $107.87 |
| Q1 2021 | +40,000 | Add 12.19% | 368,126 | $108.22 |
| Q4 2020 | +5,577 | Add 1.73% | 328,126 | $107.15 |
| Q2 2020 | +64,749 | Add 25.12% | 322,549 | $98.18 |
| Q3 2019 | +3,000 | Add 1.18% | 257,800 | $75.72 |
| Q2 2019 | -17,115 | Reduce 6.29% | 254,800 | $72.72 |
| Q1 2018 | +39,000 | Add 16.74% | 271,915 | $94.65 |
| Q4 2014 | +1,615 | Add 0.70% | 232,915 | $65.44 |
| Q4 2013 | -3,000 | Reduce 1.28% | 231,300 | $52.81 |
| Q2 2013 | +234,300 | Add 0.00% | 234,300 | $41.34 |
Robert Bruce's AbbVie Investment FAQs
Robert Bruce first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 234,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held AbbVie Inc. (ABBV) for 51 quarters since Q2 2013.
Robert Bruce's largest addition to AbbVie Inc. (ABBV) was in Q2 2013, adding 234,300 shares worth $9.68 M.
According to the latest 13F filing for Q4 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 122,500 shares of AbbVie Inc. (ABBV), valued at approximately $27.99 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 8.68% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Bruce's peak holding in AbbVie Inc. (ABBV) was 368,126 shares, as reported at the end of Q1 2021.